ArticleInvestigational new drugs2021

Apatinib with doxorubicin and ifosfamide as neoadjuvant therapy for high-risk soft tissue sarcomas: a retrospective cohort study.

Zhichao Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.